Sarah B. Shugarts, Ph.D. - Publications

Affiliations: 
2010 Pharmaceutical Sciences and Pharmacogenomics University of California, San Francisco, San Francisco, CA 
Area:
Pharmacology

3 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Bekker P, Dairaghi D, Seitz L, Leleti M, Wang Y, Ertl L, Baumgart T, Shugarts S, Lohr L, Dang T, Miao S, Zeng Y, Fan P, Zhang P, Johnson D, et al. Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study. Plos One. 11: e0164646. PMID 27768695 DOI: 10.1371/journal.pone.0164646  0.316
2013 Jacquot C, Moayeri M, Kim B, Shugarts S, Lynch KL, Leavitt AD. Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a case report. Transfusion. 53: 2715-21. PMID 23451879 DOI: 10.1111/Trf.12138  0.411
2009 Shugarts S, Benet LZ. The role of transporters in the pharmacokinetics of orally administered drugs. Pharmaceutical Research. 26: 2039-54. PMID 19568696 DOI: 10.1007/S11095-009-9924-0  0.558
Show low-probability matches.